Adam Freund

Company: Arda Therapeutics

Job title: Founder & Chief Executive Officer

Seminars:

ADC-Mediated Depletion of Pathogenic Fibroblasts Ameliorates Pulmonary Fibrosis 9:00 am

• Discussing the therapeutic potential of depleting pro-fibrotic fibroblasts • Using a single-cell-based target discovery engine to target very specific pathogenic sub-populations of cells • Developing biologics, including antibody-drug conjugates, to deplete target-positive cells • Evaluating biologics in preclinical models of pulmonary fibrosis to quantify the sensitivity and specificty of cell depletion and the effect…Read more

day: Day Two